Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease

Article Properties
  • Language
    English
  • DOI (url)
    10.2217/bmm.12.42
  • Publication Date
    2012/08/01
  • Journal
    Biomarkers in Medicine
  • Indian UGC (journal)
  • Refrences
    179
  • Citations
    79
  • Anne M Fagan Department of Neurology, Washington University School of Medicine, 660 South Euclid Ave., Campus Box 8111, St Louis, MO 63110, USA.Hope Center for Neurological Disorders, Washington University School of Medicine, 660 South Euclid Ave., St Louis, MO 63110, USAKnight Alzheimer’s Disease Research Center, Washington University School of Medicine, 660 South Euclid Ave., Campus Box 8111, St Louis, MO 63110, USA
  • Richard J Perrin Knight Alzheimer’s Disease Research Center, Washington University School of Medicine, 660 South Euclid Ave., Campus Box 8111, St Louis, MO 63110, USADivision of Neuropathy, Department of Pathology & Immunology, Washington University School of Medicine, 660 South Euclid Ave., Campus Box 8188, St Louis, MO 63110, USA
Abstract
Cite
Fagan, Anne M, and Richard J Perrin. “Upcoming Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease”. Biomarkers in Medicine, vol. 6, no. 4, 2012, pp. 455-76, https://doi.org/10.2217/bmm.12.42.
Fagan, A. M., & Perrin, R. J. (2012). Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease. Biomarkers in Medicine, 6(4), 455-476. https://doi.org/10.2217/bmm.12.42
Fagan, Anne M, and Richard J Perrin. “Upcoming Candidate Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease”. Biomarkers in Medicine 6, no. 4 (2012): 455-76. https://doi.org/10.2217/bmm.12.42.
Fagan AM, Perrin RJ. Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease. Biomarkers in Medicine. 2012;6(4):455-76.
Journal Categories
Medicine
Medicine (General)
Science
Biology (General)
Genetics
Refrences
Title Journal Journal Categories Citations Publication Date
Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

 Neurodegenerative Diseases
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
 35 2010
Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

 2010
Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

 2010
Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

 2010
Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

 2012
Citations
Title Journal Journal Categories Citations Publication Date
Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease Aging and disease
  • Medicine: Internal medicine: Special situations and conditions: Geriatrics
  • Medicine: Medicine (General)
 2024
Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals Neurobiology of Aging
  • Medicine: Internal medicine: Special situations and conditions: Geriatrics
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
 2 2023
Molecular mechanism of the carboxyl terminus of Hsc70-interacting protein in TAU hyperphosphorylation induced by AlCl3 in N2a cells Toxicology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 2023
Therapeutic strategies to recover ependymal barrier after inflammatory damage: relevance for recovering neurogenesis during development

 Frontiers in Neuroscience
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
  • Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
 2023
From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology

 International Journal of Molecular Sciences
  • Science: Biology (General)
  • Science: Chemistry: General. Including alchemy
  • Science: Chemistry
 2023
Citations Analysis
Category Category Repetition
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry40
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system23
Science: Biology (General)11
Medicine: Medicine (General)9
Science: Biology (General): Cytology7
Medicine: Internal medicine: Special situations and conditions: Geriatrics7
Science: Chemistry: Organic chemistry: Biochemistry7
Medicine: Therapeutics. Pharmacology5
Science: Chemistry: Analytical chemistry4
Science: Chemistry4
Medicine: Public aspects of medicine: Toxicology. Poisons4
Science: Biology (General): Genetics4
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system: Psychiatry4
Medicine3
Science3
Science: Science (General)3
Medicine: Internal medicine2
Medicine: Medicine (General): Medical technology2
Medicine: Pathology2
Technology: Chemical technology: Biotechnology2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the endocrine glands. Clinical endocrinology2
Agriculture: Animal culture: Veterinary medicine1
Agriculture: Plant culture1
Agriculture: Animal culture1
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials1
Technology: Chemical technology1
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens1
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy1
Medicine: Internal medicine: Specialties of internal medicine: Nutritional diseases. Deficiency diseases1
Science: Chemistry: General. Including alchemy1
Science: Microbiology1
The category Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 40 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Modeling Alzheimer's disease with non-transgenic rat models and was published in 2013. The most recent citation comes from a 2024 study titled Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer’s Disease. This article reached its peak citation in 2015, with 14 citations. It has been cited in 63 different journals, 25% of which are open access. Among related journals, the Alzheimer's Research & Therapy cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year